Fluidigm and Genomenon to Offer Evidence-Based Genomic Panel Design Service
07 juin 2018 07h00 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., June 07, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation announced today that it has entered into a co-marketing agreement with Genomenon to offer evidence-based genomic...
Biodesix Announces Biomarker Research Collaboration with Checkmate Pharmaceuticals
20 mars 2018 09h00 HE
|
Biodesix, Inc.
BOULDER, Colo., March 20, 2018 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Boulder, CO, USA), a molecular diagnostics company has entered into a biomarker research collaboration with Checkmate...
Stopping Epilepsy Before It Starts? CURE Researcher Identifies a Possible Biomarker
06 févr. 2018 09h50 HE
|
About Citizens United for Research in Epilepsy (CURE)
Chicago, Feb. 06, 2018 (GLOBE NEWSWIRE) -- New research, funded by Citizens United for Research in Epilepsy (CURE), has discovered a ‘smoking gun’ biomarker that could result in treatments that stop...
ZIVO Bioscience and Tianjin Norland Biotech Execute Letter of Intent to Produce ZIVO Algae Strain in China for International and Domestic Markets
01 févr. 2018 07h52 HE
|
Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., Feb. 01, 2018 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (OTCMKTS:ZIVO), a biotech/agtech R&D company engaged in the commercialization of nutritional and medicinal products...
Visiongain launches report entitled Alzheimer’s disease therapeutics and diagnostics market 2017-2027
11 janv. 2018 08h31 HE
|
Visiongain Ltd
LONDON, Jan. 11, 2018 (GLOBE NEWSWIRE) -- The Alzheimer’s Disease Therapeutics and Diagnostics Market reached $6.71bn in 2016. The Alzheimer’s Disease Therapeutics and Diagnostics Market is expected...
ZIVO Bioscience Subsidiary Wellmetris Selected to Present at Biotech Showcase During JPMorgan Healthcare Conference Jan 7-10 in San Francisco, CA
08 janv. 2018 08h00 HE
|
Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., Jan. 08, 2018 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (OTCMKTS:ZIVO), a biotech/agtech R&D company, announced today that its WellMetris subsidiary will be presenting at...
Data Published In AACR Journal Suggest Biodesix® Test in Development May Identify Melanoma Patients Who Could Benefit from Checkpoint Inhibitors
20 déc. 2017 10h00 HE
|
Biodesix, Inc.
BOULDER, Colo., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Findings published in the American Association for Cancer Research (AACR) peer-reviewed journal Cancer Immunology Research demonstrate that a test...
Biodesix Announces New Data Demonstrating Analytic Validity of Automated RNA Extraction from Plasma with the GeneStrat® Test
16 nov. 2017 15h40 HE
|
Biodesix, Inc.
BOULDER, Colo., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Biodesix® announced data demonstrating that a novel, automated method for extracting circulating RNA from plasma performed equivalently or better...
Fluidigm to Unveil High-Parameter Tissue Imaging System
18 oct. 2017 09h00 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Oct. 18, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that it will unveil a commercially available system for high-parameter tissue...
Global DNA Sequencing Market Expected to Reach $18,284 Million by 2023 - Allied Market Research
30 mai 2017 11h00 HE
|
Allied Market Research
Portland, United States, May 30, 2017 (GLOBE NEWSWIRE) -- According to a new report published by Allied Market Research, titled, "DNA Sequencing Market : Global Opportunity Analysis and Industry...